EBMT 2019 | The future of CAR-T cell therapy in Europe

Julio Delgado

Julio Delgado, MD, PhD, from the Clinical and Provincial Hospital of Barcelona, Spain, discusses the use of CAR T-cell therapy in Europe, and explains how use of this therapy is becoming increasingly widespread within Europe as more treatments become approved. This video was recorded at the European Society’s for Blood and Marrow Transplantation (EBMT) 2019 Annual Meeting.

Share this video  
Similar topics